A candidate identification questionnaire for patients with postmenopausal osteoporosis switched from treatment with a daily or weekly bisphosphonate to once-monthly ibandronate
Articles > Article · 2011
Authors: Y. Gokce Kutsal, N. Eskiyurt, J. Irdesel, V. Sepici, H. Ugurlu, Yeşim KİRAZLI, F. Ardic, M. Korsic, T. Vlak, M. Grlickov, S.M. Temelkova, M. Lazarov, N. Pilipovic, V. Popovic, A. Dimic, B. Kovacev, D. Ruci, A. Tafaj, E. Kucukalic-Selimovic, D. Avdic, H. Seleskovic, S. Pejicic, B. Butun, G. Akyuz, L. Cerrahoglu, O.F. Sendur, P. Yalcin, S. Oncel, M. Saridogan, T. Sarpel, M. Tosun, K. Senel, S. Gursoy, F. Cantürk, H. Demir, B. Miskic, D. Krpan, F. Skreb, S. Grazio, Z. Crncevic-Orlic, F. Ozdener, H. Oncel
Bone, International, WoS, 2011, vol 48, pp S233-S234